{"id":5232,"date":"2021-11-19T10:29:58","date_gmt":"2021-11-19T07:29:58","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5232"},"modified":"2021-11-23T10:30:49","modified_gmt":"2021-11-23T07:30:49","slug":"avrupa-ilac-ajansi-covid-19-tedavisinde-lagevrio-molnupiravir-kullanimina-iliskin-tavsiyeler-yayimladi","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/avrupa-ilac-ajansi-covid-19-tedavisinde-lagevrio-molnupiravir-kullanimina-iliskin-tavsiyeler-yayimladi\/","title":{"rendered":"Avrupa \u0130la\u00e7 Ajans\u0131, COVID-19 Tedavisinde Lagevrio (Molnupiravir) Kullan\u0131m\u0131na \u0130li\u015fkin Tavsiyeler Yay\u0131mlad\u0131"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-107750 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2021\/11\/EMA-629x108.png\" alt=\"\" width=\"256\" height=\"44\" \/><strong>Avrupa \u0130la\u00e7 Ajans\u0131 (EMA)&#8217;n\u0131n insan ila\u00e7lar\u0131 komitesi (CHMP), COVID-19 tedavisi i\u00e7in Lagevrio&#8217;nun (molnupiravir\/MK 4482) kullan\u0131m\u0131na ili\u015fkin tavsiyeler yay\u0131mlad\u0131.<\/strong><\/p>\n<p>\u015eu anda AB&#8217;de ruhsat\u0131 olmayan ila\u00e7, oksijen deste\u011fi gerektirmeyen ve ciddi COVID-19 geli\u015ftirme riski y\u00fcksek olan COVID-19&#8217;lu yeti\u015fkinlerin tedavisinde kullan\u0131labilir. Lagevrio, COVID-19 tan\u0131s\u0131 konduktan sonra m\u00fcmk\u00fcn olan en k\u0131sa s\u00fcrede ve semptomlar\u0131n ba\u015flamas\u0131ndan sonraki be\u015f g\u00fcn i\u00e7inde uygulanmal\u0131d\u0131r. Kaps\u00fcl \u015feklindeki ila\u00e7, be\u015f g\u00fcn boyunca g\u00fcnde iki kez al\u0131nmal\u0131d\u0131r.<\/p>\n<p>EMA bu tavsiyeleri, Avrupa Birli\u011fi genelinde artan COVID-19 vakalar\u0131n\u0131 ve \u00f6l\u00fcm oranlar\u0131n\u0131 g\u00f6z \u00f6n\u00fcnde tutarak, pazarlama izni \u00e7\u0131kmadan ilac\u0131n erken kullan\u0131lmas\u0131na karar vermesi gerekebilecek ulusal yetkililere destek olmak i\u00e7in yay\u0131mlad\u0131. Tavsiyeler, ilac\u0131n kalitesine ili\u015fkin verilerin yan\u0131 s\u0131ra tamamlanm\u0131\u015f veya devam eden \u00e7al\u0131\u015fmalar\u0131n sonu\u00e7lar\u0131na g\u00f6re olu\u015fturuldu.<\/p>\n<p><a href=\"https:\/\/www.ema.europa.eu\/en\/news\/ema-issues-advice-use-lagevrio-molnupiravir-treatment-covid-19\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Avrupa \u0130la\u00e7 Ajans\u0131 (EMA)&#8217;n\u0131n insan ila\u00e7lar\u0131 komitesi (CHMP), COVID-19 tedavisi i\u00e7in Lagevrio&#8217;nun (molnupiravir\/MK 4482) kullan\u0131m\u0131na ili\u015fkin tavsiyeler yay\u0131mlad\u0131. \u015eu anda AB&#8217;de ruhsat\u0131 olmayan ila\u00e7, oksijen deste\u011fi gerektirmeyen ve ciddi COVID-19 geli\u015ftirme riski y\u00fcksek olan COVID-19&#8217;lu yeti\u015fkinlerin tedavisinde kullan\u0131labilir. Lagevrio, COVID-19 tan\u0131s\u0131 konduktan sonra m\u00fcmk\u00fcn olan en k\u0131sa s\u00fcrede ve semptomlar\u0131n ba\u015flamas\u0131ndan sonraki be\u015f g\u00fcn i\u00e7inde uygulanmal\u0131d\u0131r. Kaps\u00fcl \u015feklindeki ila\u00e7, be\u015f g\u00fcn boyunca g\u00fcnde iki kez al\u0131nmal\u0131d\u0131r. EMA bu tavsiyeleri, Avrupa Birli\u011fi genelinde artan COVID-19 vakalar\u0131n\u0131 ve \u00f6l\u00fcm oranlar\u0131n\u0131 g\u00f6z \u00f6n\u00fcnde tutarak, pazarlama izni \u00e7\u0131kmadan ilac\u0131n erken kullan\u0131lmas\u0131na karar vermesi gerekebilecek ulusal yetkililere destek olmak i\u00e7in yay\u0131mlad\u0131. Tavsiyeler, ilac\u0131n kalitesine ili\u015fkin [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5232"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5232"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5232\/revisions"}],"predecessor-version":[{"id":5234,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5232\/revisions\/5234"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5233"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}